Relmada Therapeutics annual operating margin
2012
2013
Relmada Therapeutics Operating Margin Growth & History (RLMD)
Relmada Therapeutics's operating margin was −877.66% for fiscal 2013.
View full Relmada Therapeutics company overviewRelmada Therapeutics annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2013 | 2013-08-31 | −877.66% | −725.89 pp |
| 2012 · Aug 31 | 2012-08-31 | −151.77% | — |
Relmada Therapeutics quarterly operating margin
Q2.12
Q3.12
Q1.13
Q1.13
Q2.13
Q1.14
Q2.14
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2014 · Feb 28 | 2014-02-28 | −458.06% | −38.33 pp |
| Q1 2014 · Nov 30 | 2013-11-30 | −776.97% | −156.72 pp |
| Q2 2013 | 2013-05-31 | −3,073.34% | −3065.00 pp |
| Q1 2013 · Feb 28 | 2013-02-28 | −176.73% | — |
| Q1 2013 · Nov 30 | 2012-11-30 | −419.73% | — |
| Q3 2012 | 2012-05-31 | −620.25% | — |
| Q2 2012 | 2012-02-29 | −8.35% | — |
Relmada Therapeutics operating margin trends
Across the available reported history, Relmada Therapeutics's operating margin decreased from −151.77% to −877.66%, a change of −725.89 percentage points. The latest reported quarter, Q2 2014 · Feb 28, shows −458.06%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Relmada Therapeutics filings at SEC.gov ↗